Microarray Application in Newborns With Multiple Congenital Anomalies: Genotype-Phenotype Correlation
Ramazan Keçeci1, Hayriye Nermin Keçeci2, Müşerref Başdemirci3
1Division of Neonatology, Department of Pediatrics, Konya City Hospital, Konya, Turkey.
Birth Defects Research
|July 12, 2025
Summary
Microarray analysis identified copy number variations (CNVs) in 22% of newborns with multiple congenital anomalies (MCA), aiding in genetic diagnosis and counseling. This study highlights the importance of CNVs in understanding MCA causes.
Area of Science:
- Genetics
- Pediatrics
- Medical Diagnostics
Background:
- Microarray analysis is a crucial first step in diagnosing newborns with multiple congenital anomalies (MCA).
- This technique detects small copy number variations (CNVs) in DNA, aiding in the identification of genetic causes for congenital conditions.
Purpose of the Study:
- To investigate the utility of microarray analysis in identifying genetic causes of multiple congenital anomalies (MCA) in newborns.
- To evaluate the clinical significance and inheritance patterns of detected copy number variations (CNVs).
Main Methods:
- Microarray analysis was performed on 63 newborns diagnosed with MCA, excluding those with known chromosomal anomalies or teratogenic history.
- Detected CNVs were cross-referenced with databases for pathogenicity evaluation and comparison with existing patient data.
Main Results:
- Copy number variations (CNVs) were identified in 11 out of 50 (22%) analyzed patients.
- Four of the 13 detected CNVs were novel, while nine were previously reported. Nine CNVs were pathogenic, one likely pathogenic, and three of uncertain significance.
- All patients with CNVs exhibited congenital heart defects, and other common anomalies included craniofacial dysmorphism, extremity anomalies, and cleft lip/palate.
Conclusions:
- Microarray analysis is highly valuable for clinical guidance and genetic counseling in newborns with MCA.
- Further research and database expansion will improve the interpretation of novel CNVs and enhance patient management strategies.


